Alvarium Tiedemann Holdings Inc
NASDAQ:ALTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Alvarium Tiedemann Holdings Inc
NASDAQ:ALTI
|
US |
|
eFFECTOR Therapeutics Inc
OTC:EFTR
|
US |
|
Biogaia AB
STO:BIOG B
|
SE |
|
Dupont De Nemours Inc
NYSE:DD
|
US |
|
C
|
Cie Industrielle Financiere Entreprise SA
PAR:INFE
|
FR |
|
Sun Hung Kai & Co Ltd
HKEX:86
|
HK |
|
A
|
Avantel Ltd
BSE:532406
|
IN |
|
Maheshwari Logistics Ltd
NSE:MAHESHWARI
|
IN |
|
Asimilar Group PLC
LSE:ASLR
|
UK |
|
D
|
Dish TV India Ltd
BSE:532839
|
IN |
|
Karsu Tekstil Sanayi ve Ticaret AS
IST:KRTEK.E
|
TR |
|
Cepton Inc
NASDAQ:CPTN
|
US |
Cash Flow Statement
Cash Flow Statement
Alvarium Tiedemann Holdings Inc
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||
| Net Income |
5
|
3
|
1
|
(6)
|
(97)
|
52
|
(240)
|
(306)
|
(194)
|
(354)
|
(173)
|
(174)
|
(199)
|
(220)
|
(216)
|
(155)
|
|
| Depreciation & Amortization |
1
|
2
|
2
|
2
|
4
|
(8)
|
12
|
10
|
15
|
32
|
16
|
14
|
16
|
17
|
17
|
18
|
|
| Change in Deffered Taxes |
(0)
|
(0)
|
(0)
|
(0)
|
3
|
(16)
|
(16)
|
(2)
|
(20)
|
(4)
|
(13)
|
(23)
|
(21)
|
(23)
|
15
|
17
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
29
|
33
|
35
|
37
|
10
|
13
|
16
|
17
|
22
|
30
|
30
|
32
|
|
| Other Non-Cash Items |
10
|
6
|
6
|
7
|
76
|
(113)
|
194
|
334
|
137
|
324
|
127
|
103
|
149
|
170
|
122
|
90
|
|
| Cash Taxes Paid |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
|
| Cash Interest Paid |
0
|
0
|
0
|
1
|
2
|
5
|
10
|
14
|
17
|
19
|
17
|
17
|
12
|
8
|
4
|
0
|
|
| Change in Working Capital |
(2)
|
(1)
|
0
|
4
|
(46)
|
(23)
|
(27)
|
(112)
|
33
|
(14)
|
(9)
|
29
|
(11)
|
0
|
7
|
(21)
|
|
| Cash from Operating Activities |
15
N/A
|
10
-36%
|
10
-3%
|
7
-28%
|
(58)
N/A
|
(107)
-85%
|
(77)
+27%
|
(82)
-6%
|
(29)
+64%
|
(15)
+47%
|
(51)
-232%
|
(51)
+1%
|
(65)
-29%
|
(55)
+16%
|
(53)
+4%
|
(51)
+4%
|
|
| Investing Cash Flow | |||||||||||||||||
| Capital Expenditures |
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(6)
|
(8)
|
(8)
|
(7)
|
(3)
|
(1)
|
|
| Other Items |
(10)
|
(9)
|
(8)
|
(7)
|
(114)
|
(128)
|
(132)
|
(133)
|
13
|
(26)
|
(48)
|
(68)
|
(78)
|
(31)
|
(8)
|
13
|
|
| Cash from Investing Activities |
(10)
N/A
|
(9)
+13%
|
(8)
+12%
|
(7)
+5%
|
(114)
-1 475%
|
(128)
-12%
|
(132)
-3%
|
(133)
0%
|
12
N/A
|
(28)
N/A
|
(54)
-93%
|
(76)
-40%
|
(87)
-15%
|
(39)
+55%
|
(11)
+73%
|
12
N/A
|
|
| Financing Cash Flow | |||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
(0)
|
2
|
2
|
2
|
117
|
150
|
400
|
400
|
282
|
268
|
18
|
18
|
|
| Net Issuance of Debt |
7
|
9
|
8
|
9
|
8
|
45
|
51
|
126
|
52
|
(5)
|
(46)
|
(189)
|
(188)
|
(168)
|
(131)
|
0
|
|
| Other |
(12)
|
(10)
|
(10)
|
(10)
|
(11)
|
(20)
|
(22)
|
(91)
|
(34)
|
(26)
|
(42)
|
(37)
|
(27)
|
(27)
|
(10)
|
(7)
|
|
| Cash from Financing Activities |
(5)
N/A
|
(1)
+89%
|
(2)
-207%
|
(0)
+79%
|
(3)
-620%
|
27
N/A
|
30
+12%
|
36
+20%
|
135
+275%
|
119
-12%
|
312
+163%
|
174
-44%
|
67
-61%
|
74
+10%
|
(123)
N/A
|
12
N/A
|
|
| Change in Cash | |||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
(0)
|
(0)
|
1
|
(2)
|
3
|
3
|
2
|
3
|
1
|
(1)
|
(0)
|
2
|
0
|
3
|
|
| Net Change in Cash |
0
N/A
|
1
+19%
|
0
-54%
|
(1)
N/A
|
(173)
-18 930%
|
(210)
-21%
|
(177)
+16%
|
(176)
+1%
|
120
N/A
|
78
-35%
|
208
+166%
|
47
-77%
|
(85)
N/A
|
(18)
+79%
|
(186)
-960%
|
(24)
+87%
|
|
| Free Cash Flow | |||||||||||||||||
| Free Cash Flow |
15
N/A
|
10
-36%
|
9
-4%
|
7
-29%
|
(58)
N/A
|
(107)
-85%
|
(78)
+27%
|
(82)
-5%
|
(30)
+64%
|
(17)
+42%
|
(57)
-235%
|
(58)
-1%
|
(74)
-26%
|
(62)
+15%
|
(56)
+10%
|
(52)
+7%
|
|